Aspire Private Capital, LLC Bristol Myers Squibb CO Transaction History
Aspire Private Capital, LLC
- $398 Million
- Q4 2024
A detailed history of Aspire Private Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Aspire Private Capital, LLC holds 7,642 shares of BMY stock, worth $434,447. This represents 0.11% of its overall portfolio holdings.
Number of Shares
7,642
Previous 6,138
24.5%
Holding current value
$434,447
Previous $317,000
36.28%
% of portfolio
0.11%
Previous 0.08%
Shares
28 transactions
Others Institutions Holding BMY
# of Institutions
2,639Shares Held
1.46BCall Options Held
31.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA189MShares$10.7 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.02 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.28 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.43 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.43 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $121B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...